Institutional shares held 54 Million
420K calls
85.3K puts
Total value of holdings $7.28B
$56.6M calls
$11.5M puts
Market Cap $7.48B
55,491,200 Shares Out.
Institutional ownership 97.22%
# of Institutions 493


Latest Institutional Activity in RGEN

Top Purchases

Q3 2024
New York State Common Retirement Fund Shares Held: 567K ($76.5M)
Q3 2024
Artemis Investment Management LLP Shares Held: 130K ($17.5M)
Q3 2024
International Assets Investment Management, LLC Shares Held: 40.6K ($5.48M)
Q3 2024
Raymond James & Associates Shares Held: 82.3K ($11.1M)
Q3 2024
Mirae Asset Global Investments Co., Ltd. Shares Held: 12.7K ($1.72M)

Top Sells

Q3 2024
Impax Asset Management Group PLC Shares Held: 1.06M ($143M)
Q3 2024
Riverbridge Partners LLC Shares Held: 501K ($67.6M)
Q3 2024
Allspring Global Investments Holdings, LLC Shares Held: 254K ($34.3M)
Q3 2024
Stephens Investment Management Group LLC Shares Held: 500K ($67.4M)
Q3 2024
Banque Pictet & Cie Sa Shares Held: 24.5K ($3.3M)

About RGEN

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.


Insider Transactions at RGEN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
94.3K Shares
From 22 Insiders
Grant, award, or other acquisition 64.5K shares
Exercise of conversion of derivative security 25K shares
Open market or private purchase 4.82K shares
Sell / Disposition
120K Shares
From 11 Insiders
Sale (or disposition) back to the issuer 13.1K shares
Payment of exercise price or tax liability 20.5K shares
Bona fide gift 3K shares
Open market or private sale 83.3K shares

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN